SAN DIEGO, Calif.--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE) today reported revenues for the third fiscal quarter ended April 30, 2008 of $416,500, an increase of 215% from $132,400 in the third quarter last year. The Company reported a net loss of $2,466,400, or $(0.09) per share, for the current quarter, compared with a loss of $876,400, or $(0.03) per share, in third fiscal quarter last year.
